Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
As of today, Merck(MRK) shares are valued at $127.51. The company's market cap stands at 314.89B, with a P/E ratio of 35.92 and a dividend yield of 2.63%.
On 2026-07-18, Merck(MRK) stock traded between a low of $127.03 and a high of $131.74. Shares are currently priced at $127.51, which is +0.4% above the low and -3.2% below the high.
Merck(MRK) shares are trading with a volume of 13.47M, against a daily average of 9.37M.
During the past year, Merck(MRK) stock moved between $76.66 at its lowest and $131.74 at its peak.
During the past year, Merck(MRK) stock moved between $76.66 at its lowest and $131.74 at its peak.
MRK News
Technology Merck Reportedly Goes To Bat In Takeover Battle. Genomics Stock Flies. Licensing Personalis (PSNL) stock popped Friday on a rumor Merck (MRK) and at...
Personalis (PSNL) shares added ~4% in the premarket on Friday following a report indicating that the company is exploring a potential sale after receiving takeo...
Needham raised the firm’s price target on Personalis (PSNL) to $17 from $12 and keeps a Buy rating on the shares following a blog report that the company has re...
Analyst ratings
66%
of 29 ratingsMore MRK News
Merck & Company, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Jason Gerberry from Bank of America Securities maintai...
Earlier this week, Merck & Co. received U.S. FDA approval for LIPFENDRA (enlicitide), the first once-daily oral PCSK9 inhibitor, after Phase 3 trials showed sub...
Biotech and Pharma Merck Stock Rises After U.S. Approval for Powerful Cholesterol-Cutting Pill In this article AMGN REGN SAN AZN Merck stock is up around 17% so...
Merck (MRK) announced the FDA has approved hypercholesterolemia – enlicitide – tablets 20 mg as an adjunct to diet and exercise to reduce low-density lipoprotei...
Goldman Sachs analyst Asad Haider maintained a Buy rating on Merck & Company yesterday and set a price target of $137.00. TipRanks has entered a new arena in t...
Merck (MRK) is back in focus after two fresh KEYTRUDA milestones, new FDA approvals for bladder cancer regimens with Padcev, and Phase 3 success in endometrial...
Prediction: This Dividend King Could End The Year With a New All-Time High Stock Price By Vandita Jadeja Published Jul 15, 1:29PM EDT Quick Read JNJ earns a B...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.